Literature DB >> 12828875

Cancer pain and depression: management of the dual-diagnosed patient.

Alan D Valentine1.   

Abstract

Depressive disorders and pain syndromes are very common in the experience of cancer patients and may be experienced simultaneously. There is an intuitive association between cancer pain and cancer depression, both of which are multidimensional entities. Research has suggested, but not conclusively proven a cause-effect relationship. Suicidal ideation is a common concern in cancer patients with severe depression or pain. Antidepressant therapy is a mainstay of management of depression. That some antidepressants have use in the management of cancer pain may influence choice of drug selection in depressed patients. Antidepressant side effects and the patient's drug history are relevant variables. Because antidepressants that are effective as coanalgesics may not be tolerated at doses effective for depression, the clinician must be familiar with newer classes of antidepressants and psychostimulants. Combination drug therapy may be required. Psychotherapy also is common to the treatment of cancer pain and depression. With or without the intervention of pain and mental health specialists, ongoing supportive therapy from the primary clinician is essential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828875     DOI: 10.1007/s11916-003-0046-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  35 in total

Review 1.  Antidepressants in the management of cancer pain.

Authors:  T A Mays
Journal:  Curr Pain Headache Rep       Date:  2001-06

2.  Venlafaxine in neuropathic pain following treatment of breast cancer.

Authors:  Tiina Tasmuth; Brita Härtel; Eija Kalso
Journal:  Eur J Pain       Date:  2002       Impact factor: 3.931

3.  Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer.

Authors:  E Bruera; C Brenneis; A H Paterson; R N MacDonald
Journal:  J Pain Symptom Manage       Date:  1989-03       Impact factor: 3.612

4.  Psychiatric symptomatology among hospitalized cancer patients.

Authors:  T J Craig; M D Abeloff
Journal:  Am J Psychiatry       Date:  1974-12       Impact factor: 18.112

Review 5.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

Authors:  Søren H Sindrup; Troels S Jensen
Journal:  Pain       Date:  1999-12       Impact factor: 6.961

Review 6.  Depression in cancer patients.

Authors:  H M Chochinov
Journal:  Lancet Oncol       Date:  2001-08       Impact factor: 41.316

7.  Pain characteristics and treatment in an outpatient cancer population.

Authors:  J Peteet; V Tay; G Cohen; J MacIntyre
Journal:  Cancer       Date:  1986-03-15       Impact factor: 6.860

8.  Depression, Hopelessness, and suicidal ideation in the terminally ill.

Authors:  H M Chochinov; K G Wilson; M Enns; S Lander
Journal:  Psychosomatics       Date:  1998 Jul-Aug       Impact factor: 2.386

9.  The multidimensional nature of cancer-related pain.

Authors:  T A Ahles; E B Blanchard; J C Ruckdeschel
Journal:  Pain       Date:  1983-11       Impact factor: 6.961

10.  Psychotherapy during radiotherapy: effects on emotional and physical distress.

Authors:  B Forester; D S Kornfeld; J L Fleiss
Journal:  Am J Psychiatry       Date:  1985-01       Impact factor: 18.112

View more
  2 in total

1.  Cancer-related depression and potential pharmacologic therapies.

Authors:  Aimee Ginsburg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

Review 2.  [Psychooncology. New aspects for urology].

Authors:  V Köllner; K A Lautenschläger; F-G Pajonk
Journal:  Urologe A       Date:  2004-03       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.